Grupo COI - Clínicas Oncológicas Integradas

Rio de Janeiro 22775-001

0 studies enrolling now · 1 studies all time

What they study most

Medullary Thyroid Cancer

Studies at this site

• A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer — Running, not enrolling